GO:0005854 | nascent polypeptide-associated complex | 7.79% (6/77) | 10.87 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 29.87% (23/77) | 2.69 | 0.0 | 0.0 |
GO:0005840 | ribosome | 10.39% (8/77) | 5.39 | 0.0 | 0.0 |
GO:0022607 | cellular component assembly | 12.99% (10/77) | 4.01 | 0.0 | 0.0 |
GO:0051082 | unfolded protein binding | 7.79% (6/77) | 5.71 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 50.65% (39/77) | 1.34 | 0.0 | 0.0 |
GO:0003735 | structural constituent of ribosome | 9.09% (7/77) | 4.97 | 0.0 | 0.0 |
GO:0006612 | protein targeting to membrane | 6.49% (5/77) | 6.36 | 0.0 | 0.0 |
GO:0006412 | translation | 9.09% (7/77) | 4.79 | 0.0 | 0.0 |
GO:0065003 | protein-containing complex assembly | 10.39% (8/77) | 4.26 | 0.0 | 0.0 |
GO:0043043 | peptide biosynthetic process | 9.09% (7/77) | 4.67 | 0.0 | 1e-06 |
GO:1990904 | ribonucleoprotein complex | 11.69% (9/77) | 3.77 | 0.0 | 1e-06 |
GO:0044391 | ribosomal subunit | 7.79% (6/77) | 5.15 | 0.0 | 1e-06 |
GO:0022625 | cytosolic large ribosomal subunit | 6.49% (5/77) | 5.91 | 0.0 | 1e-06 |
GO:0005515 | protein binding | 28.57% (22/77) | 1.93 | 0.0 | 1e-06 |
GO:0043933 | protein-containing complex organization | 11.69% (9/77) | 3.7 | 0.0 | 1e-06 |
GO:0090150 | establishment of protein localization to membrane | 6.49% (5/77) | 5.76 | 0.0 | 1e-06 |
GO:0009059 | macromolecule biosynthetic process | 12.99% (10/77) | 3.36 | 0.0 | 1e-06 |
GO:0006518 | peptide metabolic process | 9.09% (7/77) | 4.41 | 0.0 | 1e-06 |
GO:0009987 | cellular process | 45.45% (35/77) | 1.3 | 0.0 | 1e-06 |
GO:0015934 | large ribosomal subunit | 6.49% (5/77) | 5.62 | 0.0 | 1e-06 |
GO:0043604 | amide biosynthetic process | 9.09% (7/77) | 4.27 | 0.0 | 2e-06 |
GO:0005198 | structural molecule activity | 9.09% (7/77) | 4.25 | 0.0 | 2e-06 |
GO:0043226 | organelle | 28.57% (22/77) | 1.81 | 0.0 | 2e-06 |
GO:0043229 | intracellular organelle | 28.57% (22/77) | 1.81 | 0.0 | 2e-06 |
GO:0072657 | protein localization to membrane | 6.49% (5/77) | 5.36 | 0.0 | 3e-06 |
GO:0110165 | cellular anatomical entity | 42.86% (33/77) | 1.28 | 0.0 | 4e-06 |
GO:0006605 | protein targeting | 6.49% (5/77) | 5.22 | 0.0 | 4e-06 |
GO:0043603 | amide metabolic process | 9.09% (7/77) | 3.85 | 1e-06 | 9e-06 |
GO:0051668 | localization within membrane | 6.49% (5/77) | 4.92 | 1e-06 | 1.1e-05 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 2.6% (2/77) | 9.84 | 2e-06 | 2.5e-05 |
GO:0004322 | ferroxidase activity | 2.6% (2/77) | 9.84 | 2e-06 | 2.5e-05 |
GO:0016724 | oxidoreductase activity, acting on metal ions, oxygen as acceptor | 2.6% (2/77) | 9.84 | 2e-06 | 2.5e-05 |
GO:0018282 | metal incorporation into metallo-sulfur cluster | 2.6% (2/77) | 9.84 | 2e-06 | 2.5e-05 |
GO:0034986 | iron chaperone activity | 2.6% (2/77) | 9.84 | 2e-06 | 2.5e-05 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 11.69% (9/77) | 2.94 | 3e-06 | 3.1e-05 |
GO:0016043 | cellular component organization | 14.29% (11/77) | 2.43 | 6e-06 | 6e-05 |
GO:0043228 | non-membrane-bounded organelle | 10.39% (8/77) | 3.06 | 6e-06 | 6e-05 |
GO:1901566 | organonitrogen compound biosynthetic process | 10.39% (8/77) | 3.06 | 6e-06 | 6.1e-05 |
GO:0043232 | intracellular non-membrane-bounded organelle | 10.39% (8/77) | 3.06 | 6e-06 | 6.2e-05 |
GO:0008150 | biological_process | 51.95% (40/77) | 0.9 | 7e-06 | 6.5e-05 |
GO:0016722 | oxidoreductase activity, acting on metal ions | 2.6% (2/77) | 9.07 | 7e-06 | 6.5e-05 |
GO:1901576 | organic substance biosynthetic process | 15.58% (12/77) | 2.25 | 8e-06 | 7.1e-05 |
GO:0005488 | binding | 45.45% (35/77) | 1.01 | 8e-06 | 7.2e-05 |
GO:0009058 | biosynthetic process | 15.58% (12/77) | 2.17 | 1.3e-05 | 0.000117 |
GO:0071840 | cellular component organization or biogenesis | 14.29% (11/77) | 2.28 | 1.6e-05 | 0.000143 |
GO:0044249 | cellular biosynthetic process | 14.29% (11/77) | 2.25 | 2e-05 | 0.00017 |
GO:0016530 | metallochaperone activity | 2.6% (2/77) | 8.02 | 2.9e-05 | 0.000241 |
GO:0003674 | molecular_function | 58.44% (45/77) | 0.72 | 3e-05 | 0.000251 |
GO:0051234 | establishment of localization | 15.58% (12/77) | 2.01 | 4.1e-05 | 0.00033 |
GO:0071013 | catalytic step 2 spliceosome | 3.9% (3/77) | 5.47 | 4.7e-05 | 0.000373 |
GO:0003723 | RNA binding | 11.69% (9/77) | 2.41 | 5.1e-05 | 0.000397 |
GO:0051179 | localization | 15.58% (12/77) | 1.95 | 5.8e-05 | 0.000443 |
GO:0051641 | cellular localization | 9.09% (7/77) | 2.78 | 7.6e-05 | 0.000574 |
GO:0008199 | ferric iron binding | 2.6% (2/77) | 7.2 | 8.9e-05 | 0.000658 |
GO:0140513 | nuclear protein-containing complex | 9.09% (7/77) | 2.61 | 0.000158 | 0.001144 |
GO:0005905 | clathrin-coated pit | 2.6% (2/77) | 6.72 | 0.000174 | 0.001216 |
GO:0017022 | myosin binding | 2.6% (2/77) | 6.73 | 0.000172 | 0.001221 |
GO:0005737 | cytoplasm | 12.99% (10/77) | 2.01 | 0.000184 | 0.001261 |
GO:0006879 | intracellular iron ion homeostasis | 2.6% (2/77) | 6.63 | 0.000198 | 0.001339 |
GO:0030136 | clathrin-coated vesicle | 2.6% (2/77) | 6.56 | 0.000219 | 0.001343 |
GO:0032050 | clathrin heavy chain binding | 2.6% (2/77) | 6.56 | 0.000216 | 0.001348 |
GO:0005686 | U2 snRNP | 2.6% (2/77) | 6.57 | 0.000214 | 0.001352 |
GO:0034641 | cellular nitrogen compound metabolic process | 16.88% (13/77) | 1.66 | 0.000212 | 0.001362 |
GO:0005545 | 1-phosphatidylinositol binding | 2.6% (2/77) | 6.59 | 0.000209 | 0.001362 |
GO:0048268 | clathrin coat assembly | 2.6% (2/77) | 6.59 | 0.000209 | 0.001362 |
GO:0008198 | ferrous iron binding | 2.6% (2/77) | 6.38 | 0.00028 | 0.001695 |
GO:0098590 | plasma membrane region | 2.6% (2/77) | 6.25 | 0.000333 | 0.001984 |
GO:0044237 | cellular metabolic process | 25.97% (20/77) | 1.15 | 0.000447 | 0.002584 |
GO:0006334 | nucleosome assembly | 2.6% (2/77) | 6.05 | 0.000441 | 0.002587 |
GO:0045184 | establishment of protein localization | 6.49% (5/77) | 2.96 | 0.000491 | 0.002799 |
GO:0072583 | clathrin-dependent endocytosis | 2.6% (2/77) | 5.91 | 0.000534 | 0.003004 |
GO:0015693 | magnesium ion transport | 2.6% (2/77) | 5.84 | 0.000588 | 0.003177 |
GO:0015095 | magnesium ion transmembrane transporter activity | 2.6% (2/77) | 5.84 | 0.000588 | 0.003177 |
GO:0051537 | 2 iron, 2 sulfur cluster binding | 2.6% (2/77) | 5.85 | 0.00058 | 0.003216 |
GO:0006807 | nitrogen compound metabolic process | 25.97% (20/77) | 1.11 | 0.000647 | 0.003401 |
GO:0004636 | phosphoribosyl-ATP diphosphatase activity | 1.3% (1/77) | 10.61 | 0.000641 | 0.003413 |
GO:0006900 | vesicle budding from membrane | 2.6% (2/77) | 5.71 | 0.0007 | 0.003633 |
GO:0016226 | iron-sulfur cluster assembly | 2.6% (2/77) | 5.69 | 0.000723 | 0.003661 |
GO:0031163 | metallo-sulfur cluster assembly | 2.6% (2/77) | 5.69 | 0.000723 | 0.003661 |
GO:0034728 | nucleosome organization | 2.6% (2/77) | 5.67 | 0.000737 | 0.003687 |
GO:0030135 | coated vesicle | 2.6% (2/77) | 5.59 | 0.000821 | 0.00391 |
GO:0033036 | macromolecule localization | 6.49% (5/77) | 2.79 | 0.000813 | 0.003921 |
GO:0070727 | cellular macromolecule localization | 6.49% (5/77) | 2.8 | 0.000806 | 0.003934 |
GO:0008104 | protein localization | 6.49% (5/77) | 2.8 | 0.000798 | 0.003941 |
GO:0043231 | intracellular membrane-bounded organelle | 18.18% (14/77) | 1.37 | 0.000864 | 0.00407 |
GO:1901681 | sulfur compound binding | 2.6% (2/77) | 5.54 | 0.000882 | 0.004105 |
GO:0006898 | receptor-mediated endocytosis | 2.6% (2/77) | 5.51 | 0.000919 | 0.004228 |
GO:0043227 | membrane-bounded organelle | 18.18% (14/77) | 1.36 | 0.00093 | 0.00423 |
GO:0030276 | clathrin binding | 2.6% (2/77) | 5.47 | 0.000978 | 0.0044 |
GO:0005681 | spliceosomal complex | 3.9% (3/77) | 3.96 | 0.001001 | 0.004453 |
GO:0004635 | phosphoribosyl-AMP cyclohydrolase activity | 1.3% (1/77) | 9.76 | 0.001153 | 0.005074 |
GO:0043170 | macromolecule metabolic process | 23.38% (18/77) | 1.1 | 0.001326 | 0.005774 |
GO:0006338 | chromatin remodeling | 3.9% (3/77) | 3.77 | 0.001448 | 0.006237 |
GO:0009931 | calcium-dependent protein serine/threonine kinase activity | 2.6% (2/77) | 5.13 | 0.001557 | 0.006568 |
GO:0010857 | calcium-dependent protein kinase activity | 2.6% (2/77) | 5.13 | 0.001557 | 0.006568 |
GO:0004683 | calmodulin-dependent protein kinase activity | 2.6% (2/77) | 5.11 | 0.001584 | 0.006615 |
GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 1.3% (1/77) | 9.12 | 0.001792 | 0.007407 |
GO:0006325 | chromatin organization | 3.9% (3/77) | 3.65 | 0.001848 | 0.00756 |
GO:0005684 | U2-type spliceosomal complex | 2.6% (2/77) | 4.96 | 0.001947 | 0.007887 |
GO:0042788 | polysomal ribosome | 1.3% (1/77) | 8.93 | 0.002048 | 0.008213 |
GO:0030532 | small nuclear ribonucleoprotein complex | 2.6% (2/77) | 4.8 | 0.002439 | 0.009406 |
GO:0034719 | SMN-Sm protein complex | 1.3% (1/77) | 8.68 | 0.002432 | 0.00947 |
GO:0006165 | obsolete nucleoside diphosphate phosphorylation | 1.3% (1/77) | 8.68 | 0.002432 | 0.00947 |
GO:0097525 | spliceosomal snRNP complex | 2.6% (2/77) | 4.8 | 0.00243 | 0.009649 |
GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding | 2.6% (2/77) | 4.68 | 0.002835 | 0.01083 |
GO:0120114 | Sm-like protein family complex | 2.6% (2/77) | 4.66 | 0.002926 | 0.011076 |
GO:0140104 | molecular carrier activity | 2.6% (2/77) | 4.63 | 0.003038 | 0.011394 |
GO:0046777 | protein autophosphorylation | 2.6% (2/77) | 4.62 | 0.003076 | 0.01143 |
GO:1902936 | phosphatidylinositol bisphosphate binding | 2.6% (2/77) | 4.57 | 0.003317 | 0.012214 |
GO:0071824 | protein-DNA complex organization | 3.9% (3/77) | 3.32 | 0.003485 | 0.012714 |
GO:0065004 | protein-DNA complex assembly | 2.6% (2/77) | 4.48 | 0.003752 | 0.013567 |
GO:1901981 | phosphatidylinositol phosphate binding | 2.6% (2/77) | 4.45 | 0.003867 | 0.01386 |
GO:0019538 | protein metabolic process | 15.58% (12/77) | 1.26 | 0.003932 | 0.01397 |
GO:0006897 | endocytosis | 2.6% (2/77) | 4.43 | 0.003995 | 0.014069 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 2.6% (2/77) | 4.42 | 0.004059 | 0.014173 |
GO:1901564 | organonitrogen compound metabolic process | 18.18% (14/77) | 1.13 | 0.004115 | 0.014243 |
GO:0010270 | photosystem II oxygen evolving complex assembly | 1.3% (1/77) | 7.84 | 0.004347 | 0.014922 |
GO:0000149 | SNARE binding | 2.6% (2/77) | 4.35 | 0.004445 | 0.015129 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 2.6% (2/77) | 4.34 | 0.004524 | 0.01527 |
GO:0071704 | organic substance metabolic process | 27.27% (21/77) | 0.84 | 0.004894 | 0.016115 |
GO:0051540 | metal cluster binding | 2.6% (2/77) | 4.28 | 0.004883 | 0.01621 |
GO:0051536 | iron-sulfur cluster binding | 2.6% (2/77) | 4.28 | 0.004883 | 0.01621 |
GO:0016050 | vesicle organization | 2.6% (2/77) | 4.26 | 0.004989 | 0.016296 |
GO:0044238 | primary metabolic process | 25.97% (20/77) | 0.85 | 0.005403 | 0.017231 |
GO:0000428 | DNA-directed RNA polymerase complex | 2.6% (2/77) | 4.21 | 0.005401 | 0.01736 |
GO:0098771 | inorganic ion homeostasis | 2.6% (2/77) | 4.21 | 0.005364 | 0.017379 |
GO:0005516 | calmodulin binding | 2.6% (2/77) | 4.17 | 0.005701 | 0.018037 |
GO:0016272 | prefoldin complex | 1.3% (1/77) | 7.44 | 0.00575 | 0.018052 |
GO:0000785 | chromatin | 2.6% (2/77) | 4.13 | 0.005969 | 0.018596 |
GO:0042393 | histone binding | 2.6% (2/77) | 4.12 | 0.006086 | 0.018815 |
GO:0034715 | pICln-Sm protein complex | 1.3% (1/77) | 7.23 | 0.006642 | 0.020224 |
GO:0098657 | import into cell | 2.6% (2/77) | 4.05 | 0.006631 | 0.020344 |
GO:0035091 | phosphatidylinositol binding | 2.6% (2/77) | 4.02 | 0.006877 | 0.020784 |
GO:0034062 | 5'-3' RNA polymerase activity | 2.6% (2/77) | 4.01 | 0.006987 | 0.020808 |
GO:0097747 | RNA polymerase activity | 2.6% (2/77) | 4.01 | 0.006987 | 0.020808 |
GO:0018105 | peptidyl-serine phosphorylation | 2.6% (2/77) | 3.99 | 0.007211 | 0.021163 |
GO:0018209 | peptidyl-serine modification | 2.6% (2/77) | 3.99 | 0.007211 | 0.021163 |
GO:0005634 | nucleus | 10.39% (8/77) | 1.49 | 0.00761 | 0.022173 |
GO:0030880 | RNA polymerase complex | 2.6% (2/77) | 3.94 | 0.007712 | 0.022309 |
GO:0004017 | adenylate kinase activity | 1.3% (1/77) | 7.0 | 0.007787 | 0.022366 |
GO:0000949 | aromatic amino acid family catabolic process to alcohol via Ehrlich pathway | 1.3% (1/77) | 6.86 | 0.008549 | 0.023716 |
GO:0000947 | amino acid catabolic process to alcohol via Ehrlich pathway | 1.3% (1/77) | 6.86 | 0.008549 | 0.023716 |
GO:0004737 | pyruvate decarboxylase activity | 1.3% (1/77) | 6.86 | 0.008549 | 0.023716 |
GO:0000955 | amino acid catabolic process via Ehrlich pathway | 1.3% (1/77) | 6.86 | 0.008549 | 0.023716 |
GO:0005687 | U4 snRNP | 1.3% (1/77) | 6.84 | 0.008676 | 0.023904 |
GO:1902494 | catalytic complex | 6.49% (5/77) | 1.99 | 0.008828 | 0.024158 |
GO:0008152 | metabolic process | 27.27% (21/77) | 0.77 | 0.008521 | 0.024302 |
GO:0006812 | monoatomic cation transport | 3.9% (3/77) | 2.82 | 0.009044 | 0.024582 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.3% (1/77) | 6.74 | 0.009311 | 0.024974 |
GO:0036402 | proteasome-activating activity | 1.3% (1/77) | 6.74 | 0.009311 | 0.024974 |
GO:0010207 | photosystem II assembly | 1.3% (1/77) | 6.72 | 0.009438 | 0.025148 |
GO:0030003 | intracellular monoatomic cation homeostasis | 2.6% (2/77) | 3.76 | 0.009817 | 0.025986 |
GO:0022618 | protein-RNA complex assembly | 2.6% (2/77) | 3.74 | 0.010077 | 0.026502 |
GO:0004127 | cytidylate kinase activity | 1.3% (1/77) | 6.61 | 0.0102 | 0.026651 |
GO:0004550 | nucleoside diphosphate kinase activity | 1.3% (1/77) | 6.59 | 0.010327 | 0.026809 |
GO:0071826 | protein-RNA complex organization | 2.6% (2/77) | 3.69 | 0.010675 | 0.027538 |
GO:0019238 | cyclohydrolase activity | 1.3% (1/77) | 6.45 | 0.011341 | 0.028887 |
GO:0006873 | intracellular monoatomic ion homeostasis | 2.6% (2/77) | 3.65 | 0.011271 | 0.028891 |
GO:0005682 | U5 snRNP | 1.3% (1/77) | 6.32 | 0.012481 | 0.031591 |
GO:0000105 | histidine biosynthetic process | 1.3% (1/77) | 6.23 | 0.01324 | 0.032695 |
GO:0006547 | histidine metabolic process | 1.3% (1/77) | 6.23 | 0.01324 | 0.032695 |
GO:0006811 | monoatomic ion transport | 3.9% (3/77) | 2.62 | 0.013022 | 0.032758 |
GO:0008324 | monoatomic cation transmembrane transporter activity | 3.9% (3/77) | 2.62 | 0.013178 | 0.032944 |
GO:0055080 | monoatomic cation homeostasis | 2.6% (2/77) | 3.51 | 0.013628 | 0.03345 |
GO:0005543 | phospholipid binding | 2.6% (2/77) | 3.49 | 0.013986 | 0.034122 |
GO:0000974 | Prp19 complex | 1.3% (1/77) | 6.12 | 0.014251 | 0.034355 |
GO:0055082 | intracellular chemical homeostasis | 2.6% (2/77) | 3.48 | 0.014195 | 0.034425 |
GO:0032993 | protein-DNA complex | 2.6% (2/77) | 3.46 | 0.01454 | 0.034845 |
GO:0071014 | post-mRNA release spliceosomal complex | 1.3% (1/77) | 6.05 | 0.015008 | 0.035756 |
GO:0000243 | commitment complex | 1.3% (1/77) | 5.95 | 0.016018 | 0.037937 |
GO:0050801 | monoatomic ion homeostasis | 2.6% (2/77) | 3.38 | 0.016178 | 0.038094 |
GO:0035145 | exon-exon junction complex | 1.3% (1/77) | 5.9 | 0.016648 | 0.038751 |
GO:0008540 | proteasome regulatory particle, base subcomplex | 1.3% (1/77) | 5.9 | 0.016648 | 0.038751 |
GO:0005689 | U12-type spliceosomal complex | 1.3% (1/77) | 5.87 | 0.0169 | 0.039112 |
GO:0008380 | RNA splicing | 2.6% (2/77) | 3.3 | 0.017955 | 0.041317 |
GO:0019725 | cellular homeostasis | 2.6% (2/77) | 3.27 | 0.018465 | 0.04225 |
GO:0045292 | mRNA cis splicing, via spliceosome | 1.3% (1/77) | 5.67 | 0.019417 | 0.04418 |
GO:0001054 | RNA polymerase I activity | 1.3% (1/77) | 5.64 | 0.019794 | 0.044786 |
GO:0000028 | ribosomal small subunit assembly | 1.3% (1/77) | 5.57 | 0.020799 | 0.046283 |
GO:0061024 | membrane organization | 2.6% (2/77) | 3.18 | 0.020744 | 0.046417 |
GO:0005736 | RNA polymerase I complex | 1.3% (1/77) | 5.58 | 0.020673 | 0.046515 |
GO:0050145 | nucleoside monophosphate kinase activity | 1.3% (1/77) | 5.52 | 0.021552 | 0.047696 |
GO:0015075 | monoatomic ion transmembrane transporter activity | 3.9% (3/77) | 2.34 | 0.021966 | 0.048088 |
GO:0001056 | RNA polymerase III activity | 1.3% (1/77) | 5.5 | 0.021928 | 0.048265 |
GO:0000387 | spliceosomal snRNP assembly | 1.3% (1/77) | 5.45 | 0.02268 | 0.049383 |